FDA Investigator Gerald Mierle

Gerald Mierle has conducted inspections on 246 sites in 9 countries as of 23 Jan 2009. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
246
Last Inspection Date:
23 Jan 2009
Investigator Role:
FDA Investigator
Redica ID:
100009396
Countries of Inspections:
United States of America, Netherlands, India, Switzerland, Germany, Korea (Republic of), Croatia, Spain, Turkey
FDA Investigators that have inspected at least one site in common with Gerald Mierle:
Abby Lmozeke Baker, Amanda B Athey, Amy A Johnson, Amy C Amaro, Ana P Barido, Ana S Cabrera, Andrea A Branche, Andria L Kuhlman, Anna M Brannen, Arindam Dasgupta, PhD, Barbara A Burke, Barbara A Gullick, Barbara A Rusin, Barbara J Holladay, Barbara M Frazier, Beatrice Greenberg, Billingsley, Brandi N Mcgrady, Brandon L Mariner, Brentley S Collins, Brian A Graves, Brian M Palermo, Brian R Yaun, Brian S Lynch, Brooke K Higgins, Bryan J Love, Candice C Mandera, Carrie L Doupnik, CDR Rochelle B Young, RPh, MSA, Charlean R Butler, Charles D Boison, Charlotte E Wilkins, Christine M O'leary, Courtney N Long, Cynthia A Harris, MD, RN, David L Chon, David R Heiar, Dawn C Olenjack, Decarlos A Gomez, Dellarese L Herbert, Dennis L Doupnik, Dennis R Hudson, Dianne H Milazzo, Dirk L Lincoln, Donna D Gallien, MPH, Douglas A Campbell, Dr. Sriram Subramaniam, PhD, Elizabeth A Laudig, Emmanuel A Dimaano, Jr, Esaw, Esra Toussaint, Esther A Ofori, Gail L Katz, Gajendiran Mahadevan, PhD, Gale L Glinecki, Gerald D Bromley, Jr, Gerald March, Gifford Whitehurst, Jr, Helen B Ricalde, Ingrid Y Johnson, James W Leonette, Jennifer L Jager, Jennifer L Sheehan, Joan A Loreng, Joey C West, John A Gonzalez, John A Iwen, Johnson, Jose R Hernandez, Ka L Wong, Karen Gale Sego, Karen M Bryerton, Karen M Cooper, Karen S Anthony, Kelley L Clark, Kenneth L Smalls, Kirtida Patel, Krista N Flores, La Tasham Gunter, Laurianne M Montonye, Laurie A Haxel, Laurie P Norwood, Laurissa S Flowers, LCDR Matthew R Mcnew, MPH, REHS/RS, LCDR Wilfred A Darang, Lequita M Mayhew, Linda K Weir, Linda R Kuchenthal, Linda S Mattingly, Lisa M Althar, Lori A Holmquist, Lori S Lawless, Louis G An, LT John M Mastalski, Luis A Carrion, Maira P Brading, Marc S Neubauer, Margaret Torres Vazquez, Marion W Nadeau, Marla A Cassidy, Marlene L Davis, Mary K Leslie, Mary T Carden, Matthew J Gretkierewicz, Melissa D Kalik, Melkamu Getie Kebtie, PhD, Michele M Falchek, Monique S Frazier, Nancy L Meade, Nancy L Neiger, Natasha A Dezinna, Nicholas M Smith, Nicola M Fenty Stewart, Normica G Facey, Patricia A Morrow, Paul M Chefor, Paula J Bretz, Pelekakis, Peter R Lenahan, Randy L Clarida, Richard J Bashay, Robert C Steyert, Robert S Sweeton, Ronald T Nowalk, Ronnie E Jackson, Scott M Esser, Sean R Moynihan, MPH, Shelley H Beausoleil, Sherry L Secrist, BLT DO, Shusheen A Alexander, Slatten, Stephen C Eason, Steven D Banks, Susan M Miller, Sylvia R Dooling, Tamara N Champion, Tamika E Allen, RN, Tania E Vizcaino, Tania Y Hall, Terrance L Thomas, Thomas J Hudson, Tiki J Dixon, Vien Q Le, Wanda Y Honeyblue, William D Bassett, Jr, William F Lagud, Jr, William H Linkroum

Gerald Mierle's Documents

Publish Date Document Type Title
August, 2002 FDA 483 Old Dominion Eye Foundation, Inc. - Form 483, 2002-08-05
March, 2003 FDA 483 Response Old Dominion Eye Foundation, Inc. - Form 483R, 2003-03-21
March, 2002 FDA 483 Grifols Biomat USA, Inc. - Form 483, 2002-03-20
January, 2000 FDA 483 LifeNet Health - Form 483, 2000-01-07
April, 2000 FDA 483 American Red Cross Blood Services Virginia Region - Form 483, 2000-04-20
October, 2004 EIR LifeNet Health - EIR, 2005-03-15
October, 2002 FDA 483 LifeNet Health - Form 483, 2002-10-11
May, 2003 FDA 483 Response LifeNet Health - Form 483R, 2003-05-30
May, 2003 EIR LifeNet Health - EIR, 2003-06-26
September, 2000 FDA 483 NIH Clinical Center - Form 483, 2000-09-08
August, 2002 EIR Old Dominion Eye Foundation, Inc. - EIR, 2002-08-05
September, 2001 FDA 483 Aventis Bio-Services Inc - Form 483, 2001-09-12
May, 2003 FDA 483 LifeNet Health - Form 483, 2003-05-06
August, 2000 EIR LifeNet Health - EIR, 2000-08-03
September, 2004 EIR LifeNet - EIR, 2004-10-11
March, 2003 FDA 483 Old Dominion Eye Foundation, Inc. - Form 483, 2003-03-07
January, 2000 EIR LifeNet Health - EIR, 2000-01-07
July, 2000 FDA 483 American Red Cross Norfolk Main Site - Form 483, 2000-07-06
October, 2002 EIR LifeNet Health - EIR, 2002-10-11
January, 2003 EIR LifeNet Health - EIR, 2003-01-09
August, 2002 FDA 483 Response Old Dominion Eye Foundation, Inc. - Form 483R, 2002-08-28
September, 2001 EIR Aventis Bio-Services Inc - EIR, 2001-09-12
December, 2004 FDA 483 Biotest Pharmaceuticals Corporation - Form 483, 2004-12-10
March, 2003 EIR Old Dominion Eye Foundation, Inc. - EIR, 2003-03-07

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more